These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2870640)

  • 41. Value of a single night-time dose of potassium clorazepate in anxiety: a controlled trial comparison with diazepam.
    Henderson JG
    Scott Med J; 1982 Oct; 27(4):292-6. PubMed ID: 6128788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative anxiolysis with minimal sedation in elderly patients: bromazepam or clorazepate-dipotassium?
    Erb T; Sluga M; Hampl KF; Ummenhofer W; Schneider MC
    Acta Anaesthesiol Scand; 1998 Jan; 42(1):97-101. PubMed ID: 9527752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clorazepat in the treatment of anxiety-depression syndroms in neuroses.
    Florkowski A; Kocur J; Rydzynski Z; Duszyk S; Trendak W; Gruszczyński W
    Act Nerv Super (Praha); 1989 Apr; 31(1):26-7. PubMed ID: 2571217
    [No Abstract]   [Full Text] [Related]  

  • 45. Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
    Mielke DH; Gallant DM; McFarlain RA
    Curr Ther Res Clin Exp; 1976 May; 19(5):506-11. PubMed ID: 7433
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinical trial of halazepam and clorazepate: considerations of a single bedtime dose [proceedings].
    Cohen NL; Alpert M; Friedhoff AJ
    Psychopharmacol Bull; 1981 Jan; 17(1):134-5. PubMed ID: 6112774
    [No Abstract]   [Full Text] [Related]  

  • 47. A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals.
    McRae AL; Sonne SC; Brady KT; Durkalski V; Palesch Y
    Am J Addict; 2004; 13(1):53-63. PubMed ID: 14766438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clorazepate dipotassium versus midazolam for premedication in clear corneal cataract surgery.
    Laube T; Krohner H; Franke GH; Brockmann C; Steuhl KP
    J Cataract Refract Surg; 2003 Oct; 29(10):1956-61. PubMed ID: 14604717
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A post-marketing surveillance survey on the use of dipotassium clorazepate in clinical practice in the Philippines.
    Perez GG; Tudor R
    Curr Med Res Opin; 1993; 13(3):175-81. PubMed ID: 8222745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder.
    Lader M; Scotto JC
    Psychopharmacology (Berl); 1998 Oct; 139(4):402-6. PubMed ID: 9809861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clorazepate and phenobarbital as antiepileptic drugs: a double-blind study.
    Wilensky AJ; Ojemann LM; Temkin NR; Troupin AS; Dodrill CB
    Neurology; 1981 Oct; 31(10):1271-6. PubMed ID: 6125918
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fluoxetine combined with clorazepate dipotassium and behaviour modification for treatment of anxiety-related disorders in dogs.
    Pineda S; Anzola B; Olivares A; Ibáñez M
    Vet J; 2014 Mar; 199(3):387-91. PubMed ID: 24439470
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An interim multicentre report on 677 anxious geriatric out-patients treated with buspirone.
    Napoliello MJ
    Br J Clin Pract; 1986 Feb; 40(2):71-3. PubMed ID: 2871858
    [No Abstract]   [Full Text] [Related]  

  • 55. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of clorazepate dipotassium and placebo on psychomotor skills.
    Moodley P; Golombok S; Lader M
    Percept Mot Skills; 1985 Dec; 61(3 Pt 2):1121-2. PubMed ID: 2869470
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A clinical trial of buspirone and diazepam in the treatment of generalized anxiety disorder.
    Ross CA; Matas M
    Can J Psychiatry; 1987 Jun; 32(5):351-5. PubMed ID: 3308052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of clorazepate on breathlessness and exercise tolerance in patients with chronic airflow obstruction.
    Eimer M; Cable T; Gal P; Rothenberger LA; McCue JD
    J Fam Pract; 1985 Nov; 21(5):359-62. PubMed ID: 2865326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of trazodone versus clorazepate in the treatment of HIV-positive subjects with adjustment disorders: a pilot study.
    De Wit S; Cremers L; Hirsch D; Zulian C; Clumeck N; Kormoss N
    J Int Med Res; 1999; 27(5):223-32. PubMed ID: 10689628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A single-dose anti-anxiety drug. A report from the General Practitioner Research Group.
    Practitioner; 1975 Jul; 215(1285):98-101. PubMed ID: 241987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.